Nektar Analyst And Investor Conference

Nektar Therapeutics to Host Analyst & Investor Event at 2018 ASCO Annual Meeting…

Nektar Therapeutics (NKTR) announced today that it will host an analyst and investor event with clinical investigators on Saturday, June 2, 2018 at 6:45 p.m. CDT in Chicago, IL during the 2018 American Society of Clinical Oncology (ASCO) Meeting. The event will immediately follow the oral presentation of preliminary Phase 1/2 results of PIVOT, a study of NKTR-214 in combination with nivolumab, during the Developmental Therapeutics – Immunotherapy session at the ASCO meeting.



1 Like